| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 07/31/2008 | US20080182874 e.g. 1-[6-Chloro-5-[(tricyclo[3.3.1.13,7]dec-1-ylacetyl)amino]-2-quinolinyl]-4piperidinecarboxylic acid; adamantyl-containing purinergic receptor P2X7 antagonists; antiinflammatory agent, immune or cardiovascular diseases; asthma, chronic obstructive pulmonary disease, rheumatoid arthritis |
| 07/31/2008 | US20080182873 Process for the manufacture of hmg-coa reductase inhibitors |
| 07/31/2008 | US20080182856 Novel crystalline forms of aripiprazole |
| 07/31/2008 | US20080182855 Antibacterial Quinoline Derivatives |
| 07/30/2008 | EP1950201A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 07/30/2008 | EP1948612A2 Drying methods of montelukast sodium by azeotropic removal of the solvent |
| 07/30/2008 | EP1948611A2 Process for the preparation of a leukotriene antagonist and intermediates thereof |
| 07/30/2008 | EP1948610A2 Process for making montelukast and intermediates therefor |
| 07/30/2008 | EP1592684B1 Malonamide derivatives as gamma-secretase inhibitors |
| 07/30/2008 | CN101233111A Amorphous salt of 4-(3-chiloro-4-(cycloproplylaminocarbonyl)aminophenoxy)-7-method-6-quinolinecarboxamide and process for preparing the same |
| 07/30/2008 | CN101232884A Quinoline derivatives as antibacterial agents |
| 07/30/2008 | CN101230036A Method for preparing heterocyclic aryl-aryl biphenyl compounds |
| 07/30/2008 | CN101230013A Method for preparing enamine derivates |
| 07/30/2008 | CN100406443C Process for preparing quinolone antibiotic intermediates |
| 07/30/2008 | CN100406442C 4-pyridinylmethyl sulfonamide derivatives as fungicidal plant protection agents |
| 07/30/2008 | CN100406007C Asthma and allergic inflammation modulators |
| 07/29/2008 | US7405303 e.g. 4-[(7-Hydroxy-2-ethyl-3-phenyl-4-quinolinyl)oxyphenyl]-2-propenoic acid; bone diseases, aging, osteoporosis, osteoarthritis, atherosclerosis, menopausal disorders,liver and cardiovascular disorder, breast cancer |
| 07/29/2008 | US7405230 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs |
| 07/29/2008 | US7405211 Therapeutic morpholino-substituted compounds |
| 07/29/2008 | US7404962 Combination kit used in the treatment of malaria |
| 07/29/2008 | CA2430939C Lubricating oil composition with improved soot dispersing properties comprising an aromatic oligomer |
| 07/29/2008 | CA2355711C Fungicide mixture |
| 07/29/2008 | CA2333008C New heterocyclically substituted amides, their production and their use |
| 07/24/2008 | WO2008088088A1 Composition for treatment of pancreatic cancer |
| 07/24/2008 | WO2008087628A1 Process for preparing montelukast sodium containing controlled levels of impurities |
| 07/24/2008 | WO2008068272A3 Antibacterial quinoline derivatives |
| 07/24/2008 | WO2008049047A3 Quinoline compounds |
| 07/24/2008 | WO2007120638A3 Methods and compositions for modulating glycosylation |
| 07/24/2008 | US20080177075 Use of zinc ion chelate compound such as 8-hydroxyquinoline for intra-vaginal administration to control of egg fertilization by sperm and for progeny sex determination and/or for reducing incidence of defective progeny; |
| 07/24/2008 | US20080177066 reacting 2-chloro-sustituted pteridinones with para-aminobenzamides in the presence of acid catalysts, to form pteridinone derivatives having antiproliferative activity |
| 07/24/2008 | US20080177029 Halogenation and sulfonation of a 4-hydroxy-quinolone, ring closing metathesis with 2nd generation Hoveyda's catalyst of 2-(2-(cyclopropyl-2-propenyl)aminocarbonyl)-4-hydroxy-5-alkenoyl) pyrrolidine, etherification with the quinolone; one pot process; Hepatitis C viricides |
| 07/24/2008 | US20080176897 Substituted Quinolone Carboxylic Acids, Their Derivatives, Site of Action, And Uses Thereof |
| 07/24/2008 | US20080176830 Compounds, Compositions, and Methods |
| 07/24/2008 | US20080175814 Quinoline derivatives for modulating dna methylation |
| 07/24/2008 | CA2675736A1 Composition for treatment of pancreatic cancer |
| 07/23/2008 | EP1945609A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 07/23/2008 | EP1325745B1 Preventives and remedies for complications of diabetes |
| 07/23/2008 | CN101228131A 新的杂环亚基乙酰胺衍生物 New heterocyclic derivatives subunit acetamide |
| 07/23/2008 | CN101228130A Aryloxy quinolines and uses as 5-HT6 thereof |
| 07/23/2008 | CN101228129A Fluorinated pyridine N-oxide thrombin modulators and process for N-oxidation of nitrogen containing heteroaryls |
| 07/23/2008 | CN101225089A Process for the preparation of diisopinocampheylchloroborane |
| 07/23/2008 | CN100404530C Processes for the preparation of 1-[(benzoimidazole-1yl) quinolin-8-yl] piperidin-4-ylamine derivatives |
| 07/23/2008 | CN100404508C Tetrahydroquinoline derivatives |
| 07/23/2008 | CN100404507C Method for producing the purest rac-1-{4-(2-hydroxy-3-(5-quinolyloxy)propyl) piperazin-1-yl}-2,2-diphenylethan-1-one fumarate and the product obtained therefrom |
| 07/22/2008 | US7402704 Arylsulfones and uses related thereto |
| 07/22/2008 | US7402698 1-[2-(benzylamino)-1-(3,4-dichlorophenyl)ethyl]cyclobutanol hydrochloride; norepinephrine reuptake inhibitor; antidepressant, analgesic; vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, sleep disorder, hormone replacement syndrome |
| 07/22/2008 | US7402696 exert an ACC activity-inhibiting effect that is effective in the treatment of obesity, hyperlipemia, fatty liver, hyperglycemia, impaired glucose tolerance, diabetes, diabetic complications (diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, and diabetic macroangiopathy, hyperten |
| 07/22/2008 | US7402683 Cinnamic acid amides |
| 07/22/2008 | US7402674 antidiabetic agents; type 2 diabetes |
| 07/22/2008 | US7402673 Diamine β2 adrenergic receptor agonists |
| 07/22/2008 | US7402671 UV excitable fluorescent energy transfer dyes |
| 07/22/2008 | US7402598 Arylethanolamine β2-adrenoreceptor agonist compounds |
| 07/22/2008 | US7402583 Substituted quinolines as antitumor agents |
| 07/22/2008 | CA2238171C Quinoline derivatives as nk3 antagonists |
| 07/17/2008 | WO2008083635A1 A method for the preparation of montelukast |
| 07/17/2008 | US20080171873 Converting a chiral epoxyester or epoxycarboxamide to a chiral primary epoxyamine with an alkali hypohalite; reducing to form the amine;2-benzyl-4-methyl-4-phenyl-(1-oxo-1,3-dihydroisobenzofuran-5-yl)amino-pentan-2-ol; 4-methyl-2,4-diphenyl-(1-oxo-1,3-dihydroisobenzofuran-5-yl)amino-pentan-2-ol |
| 07/17/2008 | US20080171767 N-substituted-2-alkylthio-2-(substituted aryloxy and heteroaryloxy)alkylamides and their sulphinyl and sulphonyl derivatives such as 2-(3,5-dichlorophenoxy)-2-methylthio-N-2-methylprop-2-yl acetamide; fungal infections of plants |
| 07/17/2008 | US20080171765 e.g. 1-[3-(acridin-9-ylamino)-5-hydroxymethylphenyl]-3-{4-[bis(2-chloroethyl)amino]phenyl}urea; anticarcinogenic agent; improved chemical stability and efficacy; brain tumor, breast cancer, colon cancer, leukemia, and neuroblastoma |
| 07/17/2008 | US20080171692 Substituted amides |
| 07/17/2008 | US20080169453 Near infrared ray absorbing material and near infrared ray absorbing filter |
| 07/16/2008 | EP1944305A1 Quinoline derivatives as phosphodiesterase inhibitors |
| 07/16/2008 | EP1944291A1 Optically active cyclic alcohol compound and method for producing same |
| 07/16/2008 | EP1944290A1 Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 07/16/2008 | EP1943222A1 Antibacterial active 5-chinolin derivative |
| 07/16/2008 | EP1583532B1 Quinoline derivatives as glucokinase ligands |
| 07/16/2008 | EP1527049B1 Fused heterocyclic compounds as peptidase inhibitors |
| 07/16/2008 | EP1392655B1 Potassium channel openers |
| 07/16/2008 | EP1318835B1 Use of imidazoquinolinamines as adjuvants in dna vaccination |
| 07/16/2008 | CN101223143A 3-cyanoquinoline inhibitors of TPL2 kinase and methods of making and using the same |
| 07/16/2008 | CN101223142A Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors |
| 07/16/2008 | CN101223136A New benzoheterocyclylethylbenzamide derivatives |
| 07/16/2008 | CN101219992A Crystalline forms of pitavastatin calcium |
| 07/16/2008 | CN101219991A Method for producing pitavastatin calcium raw material |
| 07/16/2008 | CN101219987A New nitrogen-containing heterocyclic derivative and organic electroluminescent element using the same |
| 07/16/2008 | CN100402501C Aminoquinoline derivatives and their use as adenosine A3 ligands |
| 07/16/2008 | CN100402500C Ethoxy chinoline production method |
| 07/15/2008 | US7399865 such as (E)-N-{4-[4-(benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide used as antineoplastic agents, or inhibitors of the HER-2 gene or proteins and epidermal growth factor receptor enzymes |
| 07/15/2008 | US7399864 Such as 6-(4-(1-cyclohexyl-1,2,3,4-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril by reacting carbonstyril compound and tetrazole compound in presence of phase transfer catalyst in water; for producing cilostazol by recrystallization |
| 07/15/2008 | US7399863 e.g. 5-((R)-2-{2-[4-((R)-2-amino-2-phenylethylamino)phenyl]ethylamino}-1-hydroxy-ethyl)-8-hydroxy-1H-quinolin-2-one; premature labor, neurological disorders, cardiac disorders, and inflammation |
| 07/15/2008 | US7399862 5-HT4 receptor agonist compounds |
| 07/15/2008 | US7399775 β-amyloid protein production/secretion inhibitor |
| 07/15/2008 | US7399765 Substituted diazabicycloalkane derivatives |
| 07/15/2008 | US7399434 Rare metal compounds and mixtures of these |
| 07/15/2008 | CA2338334C Process for producing quinoline derivative and intermediate |
| 07/10/2008 | WO2008082381A1 Immune response modifier formulations containing oleic acid and methods |
| 07/10/2008 | WO2008058118A3 Preparation of montelukast and its salts |
| 07/10/2008 | US20080167468 Silacycle compounds and methods of use thereof |
| 07/10/2008 | US20080167288 Substituted cyclic hydroxamates as lnhibitors of matrix metalloproteinases |
| 07/10/2008 | US20080166593 Organic Electroluminescent Devices |
| 07/10/2008 | CA2643679A1 Immune response modifier formulations containing oleic acid and methods |
| 07/09/2008 | EP1941881A1 Dermatitis remedies |
| 07/09/2008 | EP1941872A1 Use of TNF-alpha inhibitors for treating nerve root injury |
| 07/09/2008 | EP1940795A1 N-oxo-heterocycle and n-oxo-alkyl quinoline-4-carboxamides as nk-3 receptor ligands |
| 07/09/2008 | EP1940794A2 Quinoline derivatives and use as antitumor agents |
| 07/09/2008 | EP1940793A2 A process for the preparation of montelukast |
| 07/09/2008 | EP1673084B1 1-2' (1,4'-biperidin-1'-yl)-1-(phenyl)-ethylcyclohexanol derivatives as monoamine reuptake modulators for the treatment of vasomotor symptoms |
| 07/09/2008 | EP1332133B1 Metabotropic glutamate receptor antagonists |
| 07/09/2008 | CN101218203A Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the ss2 adrenergic receptor |
| 07/09/2008 | CN100400523C Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 07/08/2008 | US7396934 Process for preparing 3-fluoroquinolines |